Grade 3/4 neutropenia is a limiting factor in second-line FOLFIRI following FOLFOX4 failure in elderly patients with metastatic colorectal cancer

Previous studies have reported improved outcomes for elderly patients with metastatic colorectal cancer (mCRC) treated with oxaliplatin or irinotecan as first-line chemotherapy. However, few studies regarding second-line chemotherapy with oxaliplatin or irinotecan are currenlty available. We analyze...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: KUBOKI, YASUTOSHI, MIZUNUMA, NOBUYUKI, OZAKA, MASATO, OGURA, MARIKO, SUENAGA, MITSUKUNI, SHINOZAKI, EIJI, MATSUSAKA, SATOSHI, CHIN, KEISHOU, MATSUURA, MASAAKI, HATAKE, KIYOHIKO
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2011
Teme:
Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3410456/
https://ncbi.nlm.nih.gov/pubmed/22866109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2011.260
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items